PSPhillipa B. Sharpe

Phillipa B. Sharpe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Phillipa B. Sharpe has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • A. Chan

    South Australian Birth Defects Register, South Australian Clinical Genetics Service, Women's and Children's Hospital

    1 shared publication
  • Annabelle Chan

    South Australian Birth Defects Register, Women's and Children's Hospital, North Adelaide, South Australia, Australia

    1 shared publication
  • C. Hasler

    Department of Orthopaedics and

    1 shared publication
  • C. Hirte

    Public Health Research Unit, Women's and Children's Hospital, Adelaide, South Australia

    1 shared publication
  • E. Haan

    South Australian Birth Defects Register, South Australian Clinical Genetics Service, Women's and Children's Hospital

    1 shared publication
  • Eric A. Haan

    South Australian Birth Defects Register, Women's and Children's Hospital, North Adelaide, South Australia, Australia

    1 shared publication

Latest Publications

  • Maternal diabetes and congenital anomalies in South Australia 1986–2000: A population‐based cohort study

    by Phillipa B. Sharpe, Annabelle Chan, Eric A. Haan, Janet E. Hiller

    BACKGROUND: This study examined the risk of congenital anomalies in infants born in South Australia to women with maternal diabetes in a population‐based cohort study of births over a 15‐year period, 1986–2000. Differences in the reporting, recording, and diagnosis of preexisting diabetes mellitus, gestational diabetes mellitus, and impaired glucose tolerance make comparisons between studies difficult. In order to compare published research, details of research methods and analytic approaches are required to understand the potential confounding, bias, and effect modification that may occur.METHODS: Data on congenital anomalies from the South Australian Birth Defects Register were linked to birth data from the Pregnancy Outcome Statistics Unit of the South Australian Department of Health. This enabled information on congenital anomalies to be linked to pregnancy details, including diabetes status.RESULTS: Between 1986 and 2000, the prevalence of congenital anomalies in the infants of mothers with preexisting diabetes mellitus, gestational diabetes mellitus, or impaired glucose tolerance was significantly higher than in the total population; relative risk = 2.01 (1.66–2.43) and 1.19 (1.08–1.31), respectively. This increased prevalence was not modified by adjustments for maternal age, ethnicity, or other demographic factors, nor did the rate change over the 15 years of the study period.CONCLUSIONS: The prevalence of congenital anomalies was found to be significantly higher in the infants of mothers with maternal diabetes. Larger population‐based studies are needed to determine which anomalies are involved and how their occurrence can be reduced. Birth Defects Research (Part A), 2005.


  • A South Australian population‐based study of congenital talipes equinovarus

    by R. Byron‐Scott, P. Sharpe, C. Hasler, P. Cundy, C. Hirte, A. Chan, H. Scott, P. Baghurst, E. Haan

    Summary: The aims of this study were to provide a population‐based prevalence for congenital talipes equinovarus (CTEV), to conduct an epidemiological investigation into the risk factors for CTEV and describe associated features. The study used a retrospective case–control design of CTEV notified to the South Australian Birth Defects Register between 1986 and 1996 inclusive, linking characteristics of mother and baby from the perinatal data collection.The prevalence of isolated CTEV was 1.1/1000 total births (n = 231). Four factors were significantly associated with an increased risk of CTEV: maternal Aboriginal race (ORadj = 2.0; 95% CI 1.1, 3.6), male gender (ORadj = 2.4; 95% CI 1.8, 3.2), maternal anaemia (ORadj = 1.8; 95% CI 1.0, 2.9) and maternal hyperemesis (ORadj = 3.6; 95% CI 1.3, 9.8). The prevalence of CTEV associated with another birth defect or syndrome (n = 157) was 0.7/1000 total births. CTEV was associated with specific birth defects and also with oligohydramnios when another birth defect was present.